Karyopharm Therapeutics (25K0.MU) Q2 2026 Earnings

5MayConfirmed
Q1 2026
Next
-4.81
-3.61
-2.41
-1.21

Details

Expected EPS
-1.21209657933
Actual EPS
N/A
Surprise EPS
1.21
Surprise Percent
+100%

Description

Karyopharm Therapeutics (25K0.MU) will report earnings of for Q2 2026 on May 05, 2026.

0 Comments

Share your thoughts